The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...
NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...
Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...
NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...
Almost 30,000 people in England with COPD (chronic obstructive pulmonary disease) could have their lives transformed after the National Institute for Health and Care Excellence recommended a new ...
Nuance Pharma ("Nuance") today announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA) for Ohtuvayre® ...
For each year of increase in menopausal age, COPD risk was reduced by 1.2%, and current smokers reached menopause 1.402 years earlier than never smokers. Menopausal age has a strong association with ...
Pune region has reported the highest concentration of extra-pulmonary tuberculosis cases in Maharashtra, making it one of the worst-affected areas in the state ...
Temple Health is testing a tiny, flexible scaffold aimed at relieving a common problem for emphysema patients: overinflation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results